HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study. - Qu, Kang; Li, Ming-xi; Yu, Peng; Palotie, Aarno; Pressman, Alice; Belin, Andrea C.; Bjornsdottir, Anna; van den Maagdenberg, Arn M. J. M.; Harder, Aster V. E.; Winsvold, Bendik S.; Müller-Myhsok, Bertram; Cormand, Bru; et al. (Scientific Reports, 2024)